Related Experiment Video
Updated: Jun 25, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Alternative driver pathways in peripheral nerve sheath tumors - including DICER1 and/or KRAS alterations
Hsin-Yi Chang1,2, Carla Saoud2, Dianne Torrence3
1Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Abstract:
DICER1-associated sarcoma is an emerging entity, defined by either somatic or germline dicer 1, ribonuclease III (DICER1) mutations and sharing characteristic morphologic features irrespective of the site of origin. In addition to the DICER1 driver mutation, concurrent genomic alterations, including tumor protein 53 (TP53) inactivation and RAS pathway activation, are frequently detected. Tumors that morphologically resemble malignant peripheral nerve sheath tumor (MPNST) have rarely been reported among DICER1 sarcomas and often pose diagnostic challenges. This study was prompted by a case involving morphologic features of MPNST, which harbored co-existing DICER1 and hotspot KRAS mutations. Hence, we investigated the incidence of these alterations in PNST from our molecular database compared to the genomic and morphologic spectrum of DICER1-mutant sarcomas. In total, we identified three cases diagnosed as MPNST with co-existing DICER1, ATRX chromatin remodeler (ATRX), and KRAS G12V/A alterations occurring in brain, cerebellopontine angle, and intra-abdominal sites. Two additional cases each of MPNSTs and neurofibromas were identified with hotspot KRAS mutations. All five MPNSTs lacked canonical neurofibromin 1 (NF1)/neurofibromin 2 (NF2) alterations, displaying a classic morphologic appearance with fascicular monomorphic spindle cells and followed a diverse clinical behavior. Among the 38 DICER1-associated sarcomas in our database, eight (21%) had secondary KRAS hotspot mutations, all composed of monomorphic spindle and/or round cells, including three with an MPNST-like histology. In contrast, all 10 (26%) DICER1-mutant sarcomas with TP53 mutations showed a pleomorphic phenotype. The DNA-based methylation profile of our index case clustered within the group of sarcomas with DICER1 alterations. Our results highlight a small subset of MPNST associated with DICER1 and/or KRAS mutations. However, their relationship with conventional MPNST remains to be determined in larger studies. © 2025 The Pathological Society of Great Britain and Ireland.
Insights
DICER1-mutant sarcomas can mimic malignant peripheral nerve sheath tumors (MPNSTs), particularly when KRAS mutations are present. This study identifies a subset of MPNSTs with DICER1 and/or KRAS alterations, distinct from conventional MPNSTs.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- DICER1-associated sarcomas are an emerging group of tumors characterized by DICER1 mutations.
- Concurrent genetic alterations like TP53 inactivation and RAS pathway activation are common in these sarcomas.
- Tumors resembling malignant peripheral nerve sheath tumors (MPNSTs) are rarely reported in DICER1 sarcomas and present diagnostic challenges.
Purpose of the Study:
- To investigate the incidence of DICER1 and KRAS mutations in MPNSTs.
- To compare the genomic and morphologic features of MPNSTs with DICER1-mutant sarcomas.
- To characterize a specific subset of MPNSTs associated with DICER1 and/or KRAS alterations.
Main Methods:
- Analysis of a molecular database for DICER1, KRAS, ATRX, TP53, NF1, and NF2 alterations in MPNSTs and DICER1-mutant sarcomas.
- Morphologic evaluation of tumor samples.
- DNA-based methylation profiling.
Main Results:
- Three cases of MPNST with co-existing DICER1, ATRX, and KRAS G12V/A alterations were identified.
- Eight of 38 (21%) DICER1-associated sarcomas harbored secondary KRAS hotspot mutations, with three showing MPNST-like histology.
- DICER1-mutant sarcomas with TP53 mutations (10/38, 26%) displayed a pleomorphic phenotype, contrasting with the monomorphic cells in KRAS-mutated sarcomas.
Conclusions:
- A distinct subset of MPNSTs associated with DICER1 and/or KRAS mutations exists.
- These MPNSTs lack canonical NF1/NF2 alterations and exhibit monomorphic spindle cell morphology.
- Further research is needed to clarify the relationship between these MPNSTs and conventional MPNSTs.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Related Concept Videos
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Ras Gene
Ras is a superfamily...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity: